Rigel Pharmaceuticals Inc (FRA:RI2)
€ 33.87 -0.66 (-1.91%) Market Cap: 651.15 Mil Enterprise Value: 603.10 Mil PE Ratio: 2.35 PB Ratio: 1.69 GF Score: 24/100

Rigel Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript

Jan 14, 2026 / 11:00 PM GMT
Release Date Price: €32.4 (+0.62%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

RIGL.OQ - Rigel Pharmaceuticals Inc
Rigel Pharmaceuticals Inc at JPMorgan Healthcare Conference
Jan 14, 2026 / 11:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Hi everyone. My name is Denise Lee. I am an associate on the Healthcare Investment banking team here. So, we are excited to be continuing the forty-fourth annual Healthcare Conference this afternoon and it is my pleasure to introduce Raul Rodriguez, CEO and President of Rigel Pharmaceuticals.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, Denise, and thank you to our colleagues at JP Morgan for having invited us to present. I'm excited to be in front of you and sharing this story.

First, some important forward-looking statements. These
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot